SEC Form 3 · accession 0001672014-16-000001
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Akin
Director
Period of report
Feb 29, 2016
Accepted (ET)
May 2, 2016 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | holding | — | — | — | 5,090,742 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $1.00 | holding | — | — | — | Nov 5, 2012 | Nov 4, 2017 | Common Stock | 250,000 | — | D |
| Warrant | $0.20 | holding | — | — | — | Feb 16, 2016 | Feb 15, 2021 | Common Stock | 1,000,000 | — | D |
Remarks
Original Form 3 Not Timely Filed